Cyclooxygenase-2 inhibition and renal function.
Pfister
A K
AK
Crisalli
R J
RJ
Carter
W H
WH
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002057:Burns, Chemical / Q000150:complications; D000068579:Celecoxib; D051546:Cyclooxygenase 2; D004231:Diuresis / Q000187:drug effects*; D005260:Female; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors*; D007668:Kidney / Q000187:drug effects* / Q000503:physiopathology; D008565:Membrane Proteins; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy; D010996:Pleural Effusion / Q000209:etiology / Q000628:therapy; D011451:Prostaglandin-Endoperoxide Synthases; D011720:Pyrazoles; D012008:Recurrence; D013449:Sulfonamides / Q000009:adverse effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007527:Isoenzymes; D008565:Membrane Proteins; D011720:Pyrazoles; D013449:Sulfonamides; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; D000068579:Celecoxib